市場調查報告書
商品編碼
1087247

胜肽治療藥的全球市場:產業分析,趨勢,市場規模,及預測(∼2028年)

Peptide Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028

出版日期: | 出版商: Infinium Global Research (IGR) | 英文 100 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球胜肽治療藥的市場規模在2022∼2028年的預測期間中預計將以10%的年複合成長率成長。

本報告提供全球胜肽治療藥市場調查,提供市場概要,市場規模和預測,趨勢,成長要素及阻礙因素,行銷類型·用途·給藥途徑·各地區的分析等全面性資訊。

目錄

第1章 序文

  • 報告的說明
  • 調查方法
  • 研究途徑

第2章 摘要整理

  • 胜肽治療藥市場概況
  • 胜肽治療藥市場預測
  • 胜肽治療藥市場地區的亮點

第3章 全球胜肽治療藥市場概要

  • 簡介
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 胜肽治療藥市場上COVID-19的影響分析
  • 波特的五力分析
  • IGR-成長矩陣分析
    • IGR-各行銷類型的成長矩陣分析
    • IGR-各用途的成長矩陣分析
    • IGR-各給藥途徑的成長矩陣分析
    • IGR-各地區的成長矩陣分析
  • 胜肽治療藥市場價值鏈分析

第4章 胜肽治療藥市場宏觀指標分析

第5章 全球胜肽治療藥市場:各行銷類型

  • 非專利
  • 品牌

第6章 全球胜肽治療藥市場:各用途

  • 腸胃障礙
  • 神經病變
  • 代謝障礙
  • 癌症
  • 其他的用途

第7章 全球胜肽治療藥市場:各給藥途徑

  • 非口服
  • 口服
  • 其他的給藥途徑

第8章 全球胜肽治療藥市場:各地區(2022年∼2028年)

  • 北美
    • 各行銷類型的北美的胜肽治療藥市場
    • 各用途的北美的胜肽治療藥市場
    • 各給藥途徑的北美的胜肽治療藥市場
    • 各國北美的胜肽治療藥市場
  • 歐洲
    • 各行銷類型的歐洲的胜肽治療藥市場
    • 各用途的歐洲的胜肽治療藥市場
    • 各給藥途徑的歐洲的胜肽治療藥市場
    • 各國歐洲的胜肽治療藥市場
  • 亞太地區
    • 各行銷類型的亞太地區的胜肽治療藥市場
    • 各用途的亞太地區的胜肽治療藥市場
    • 各給藥途徑的亞太地區的胜肽治療藥市場
    • 各國亞太地區的胜肽治療藥市場
  • 其他地區
    • 各行銷類型的其他地區的胜肽治療藥市場
    • 各用途的其他地區的胜肽治療藥市場
    • 各給藥途徑的其他地區的胜肽治療藥市場
    • 各子地區的其他地區的胜肽治療藥市場

第9章 企業簡介和競爭情形

  • 全球胜肽治療藥市場競爭情形
  • 企業簡介
    • Teva Pharmaceutical Industries Ltd.
    • Takeda Pharmaceutical Co. Ltd.
    • Sanofi SA
    • Pfizer Inc
    • Novartis AG
    • GlaxoSmithKline Plc
    • Hoffmann-La Roche Ltd.
    • Eli Lilly and Co.,
    • Bachem Holding AG
    • Amgen Inc.
目錄
Product Code: HC0179

The report on the global peptide therapeutics market provides qualitative and quantitative analysis for the period from 2020 to 2028. The report predicts the global peptide therapeutics market to grow with a CAGR of 10% over the forecast period from 2022-2028. The study on peptide therapeutics market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2020 to 2028.

The report on peptide therapeutics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global peptide therapeutics market over the period of 2020 to 2028. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global peptide therapeutics market over the period of 2020 to 2028. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report findings

1) Drivers

  • Rising prevalence of metabolic disorder
  • Increasing pool of cancer patient

2) Restraints

  • Availability of substitutes

3) Opportunities

  • Increasing cancer populations across the globe with technological advancements

Research Methodology

A) Primary Research

Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include

  • 1. Key Opinion Leaders associated with Infinium Global Research
  • 2. Internal and External subject matter experts
  • 3. Professionals and participants from the industry

Our primary research respondents typically include

  • 1. Executives working with leading companies in the market under review
  • 2. Product/brand/marketing managers
  • 3. CXO level executives
  • 4. Regional/zonal/ country managers
  • 5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

  • 1. Company reports and publications
  • 2. Government/institutional publications
  • 3. Trade and associations journals
  • 4. Databases such as WTO, OECD, World Bank, and among others.
  • 5. Websites and publications by research agencies

Segment Covered

The global peptide therapeutics market is segmented on the basis of marketing type, application, and route of administration.

The Global Peptide Therapeutics Market by Marketing Type

  • Generic
  • Branded

The Global Peptide Therapeutics Market by Application

  • Gastrointestinal Disorders
  • Neurological Disorders
  • Metabolic Disorders
  • Cancer
  • Other Applications

The Global Peptide Therapeutics Market by Route of Administration

  • Parenteral
  • Oral
  • Other Routes of Administration

Company Profiles

The companies covered in the report include

  • Teva Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Co. Ltd.
  • Sanofi SA
  • Pfizer Inc
  • Novartis AG
  • GlaxoSmithKline Plc
  • Hoffmann-La Roche Ltd.
  • Eli Lilly and Co.,
  • Bachem Holding AG
  • Amgen Inc.

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the peptide therapeutics market.

2. Complete coverage of all the segments in the peptide therapeutics market to analyze the trends, developments in the global market and forecast of market size up to 2028.

3. Comprehensive analysis of the companies operating in the global peptide therapeutics market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Table of Contents

1. Preface

  • 1.1. Report Description
  • 1.2. Research Methods
  • 1.3. Research Approaches

2. Executive Summary

  • 2.1. Peptide Therapeutics Market Highlights
  • 2.2. Peptide Therapeutics Market Projection
  • 2.3. Peptide Therapeutics Market Regional Highlights

3. Global Peptide Therapeutics Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
    • 3.2.2. Restraints
    • 3.2.3. Opportunities
  • 3.3. Analysis of COVID-19 impact on the Peptide Therapeutics Market
  • 3.4. Porter's Five Forces Analysis
  • 3.5. IGR-Growth Matrix Analysis
    • 3.5.1. IGR-Growth Matrix Analysis by Marketing Type
    • 3.5.2. IGR-Growth Matrix Analysis by Application
    • 3.5.3. IGR-Growth Matrix Analysis by Route of Administration
    • 3.5.4. IGR-Growth Matrix Analysis by Region
  • 3.6. Value Chain Analysis of Peptide Therapeutics Market

4. Peptide Therapeutics Market Macro Indicator Analysis

5. Global Peptide Therapeutics Market by Marketing Type

  • 5.1. Generic
  • 5.2. Branded

6. Global Peptide Therapeutics Market by Application

  • 6.1. Gastrointestinal Disorders
  • 6.2. Neurological Disorders
  • 6.3. Metabolic Disorders
  • 6.4. Cancer
  • 6.5. Other Applications

7. Global Peptide Therapeutics Market by Route of Administration

  • 7.1. Parenteral
  • 7.2. Oral
  • 7.3. Other Routes of Administration

8. Global Peptide Therapeutics Market by Region 2022-2028

  • 8.1. North America
    • 8.1.1. North America Peptide Therapeutics Market by Marketing Type
    • 8.1.2. North America Peptide Therapeutics Market by Application
    • 8.1.3. North America Peptide Therapeutics Market by Route of Administration
    • 8.1.4. North America Peptide Therapeutics Market by Country
  • 8.2. Europe
    • 8.2.1. Europe Peptide Therapeutics Market by Marketing Type
    • 8.2.2. Europe Peptide Therapeutics Market by Application
    • 8.2.3. Europe Peptide Therapeutics Market by Route of Administration
    • 8.2.4. Europe Peptide Therapeutics Market by Country
  • 8.3. Asia-Pacific
    • 8.3.1. Asia-Pacific Peptide Therapeutics Market by Marketing Type
    • 8.3.2. Asia-Pacific Peptide Therapeutics Market by Application
    • 8.3.3. Asia-Pacific Peptide Therapeutics Market by Route of Administration
    • 8.3.4. Asia-Pacific Peptide Therapeutics Market by Country
  • 8.4. RoW
    • 8.4.1. RoW Peptide Therapeutics Market by Marketing Type
    • 8.4.2. RoW Peptide Therapeutics Market by Application
    • 8.4.3. RoW Peptide Therapeutics Market by Route of Administration
    • 8.4.4. RoW Peptide Therapeutics Market by Sub-region

9. Company Profiles and Competitive Landscape

  • 9.1. Competitive Landscape in the Global Peptide Therapeutics Market
  • 9.2. Companies Profiles
    • 9.2.1. Teva Pharmaceutical Industries Ltd.
    • 9.2.2. Takeda Pharmaceutical Co. Ltd.
    • 9.2.3. Sanofi SA
    • 9.2.4. Pfizer Inc
    • 9.2.5. Novartis AG
    • 9.2.6. GlaxoSmithKline Plc
    • 9.2.7. Hoffmann-La Roche Ltd.
    • 9.2.8. Eli Lilly and Co.,
    • 9.2.9. Bachem Holding AG
    • 9.2.10. Amgen Inc.